glucagon receptor raises a handful of sensible questions. This page answers them in order, starting with the fundamentals and moving to applications.
Reviewed 2025-11-14. Anything still debated is marked as such rather than presented as settled.
Peptides in this class degrade mainly through hydrolysis, oxidation, and aggregation. The lipid modification improves plasma residence time but can also promote self-association in aqueous solution at higher concentrations. Oxidation of methionine and deamidation of asparagine residues are common chemical liabilities that accumulate during storage. Stability studies therefore track purity loss, aggregate formation, and changes in receptor-binding potency over time under defined temperature and humidity conditions.
Solid peptide is generally held as a lyophilised powder at low temperature to slow degradation, with desiccant to limit moisture uptake. Reconstituted solutions are less stable and are usually kept refrigerated and protected from light for short periods. Repeated freeze-thaw cycles are avoided because they encourage aggregation. Laboratory handling includes work in a fume hood or laminar flow cabinet to limit inhalation and contamination. Weighing and transfer steps are performed with antistatic tools to reduce static-driven loss of fine powder.
Published information places retatrutide in clinical development rather than on the market as an approved therapy. Early-stage and mid-stage trials have examined tolerability and changes in body weight, and larger studies continue to report results over time. Open questions include the durability of effects after treatment stops, the composition of weight lost, and cardiovascular outcomes over long periods. Statements about definitive benefit should therefore be treated as provisional. Regulatory status varies by jurisdiction and changes as applications are reviewed.
Retatrutide is an investigational synthetic peptide designed to activate three distinct receptor systems within a single molecule. Its pharmacological profile combines activity at the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This arrangement places it within a broader class of agents often described as multi-agonists, which contrast with compounds that engage one or two targets. Research interest centers on whether simultaneous signaling produces effects that single-receptor agonists cannot achieve alone. A single molecular entity also simplifies manufacturing and delivery logistics compared with combining separate agents.
| Property | Value | Notes |
|---|---|---|
| Storage temperature (solid) | -20 °C or below | Freezer storage with desiccant |
| Solubility | Soluble in water and aqueous buffer | Careful dissolution needed at higher concentrations |
| Appearance | White to off-white lyophilised powder | Visual inspection for discolouration |
| Primary analytical method | Reversed-phase HPLC with UV detection | Paired with mass spectrometry for identity |
| Common synonyms | Triple-agonist peptide; GLP-1/GIP/glucagon agonist | Naming varies across the literature |
Receptor activation produces downstream effects that differ by tissue. GLP-1 receptor signaling influences appetite regulation and insulin secretion in a glucose-dependent manner. GIP receptor activity contributes to metabolic handling of nutrients and may modulate adipose tissue. Glucagon receptor engagement raises energy expenditure and promotes hepatic lipid turnover, though the balance among these actions in humans is still being characterized. Preclinical models showed reductions in body weight and improved glycemic markers.
Clinical development has progressed through phase 2 trials in adults with obesity and type 2 diabetes, with phase 3 programs reported as ongoing. Reported outcomes include reductions in body weight and improvements in glycemic measures over defined treatment periods. Whether these effects translate into durable benefits after treatment ends remains an open question. Long-term safety data across broad populations are not yet complete, and regulatory decisions have not been announced.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
The intended pharmacology combines three signals in one molecule. GLP-1 receptor activation reduces appetite and slows gastric emptying, effects already exploited by approved incretin-based therapies. GIP receptor engagement is associated with improved insulin sensitivity and with direct effects on adipose tissue, although how much it contributes to overall outcomes is still debated. Glucagon receptor agonism raises energy expenditure and supports hepatic lipid handling, a mechanism that also tends to increase glucose output. The triple profile is hypothesized to produce a larger metabolic effect than single or dual agonism, but the relative weight of each receptor in humans is not settled.
Human evidence remains limited to controlled studies. A phase 2 trial in adults with obesity reported large, dose-dependent reductions in body weight over 48 weeks, with gastrointestinal events as the most frequently recorded adverse effect. Phase 3 programs designated TRIUMPH, for obesity, and TRANSCEND, for type 2 diabetes, are intended to confirm efficacy and to characterize safety in larger populations. Related studies are examining conditions such as knee osteoarthritis in people with obesity and metabolic liver disease. Open questions include long-term tolerability, effects on lean mass, and what happens after treatment is stopped.
The high pressure is necessary to achieve a constant flow rate for reproducible chromatography experiments. Depending on the partitioning between the mobile and stationary phases, the components of the sample will flow out of the column at different times. The column is the most important component of the LC system and is designed to withstand the high pressure of the liquid. Conventional LC columns are 100–300 mm long with an outer diameter of 6.4 mm (1/4 inch) and an internal diameter of 3.0–4.6 mm. For applications involving LC–MS, the length of chromatography columns can be shorter (30–50 mm) with 3–5 μm diameter packing particles. In addition to the conventional model, other LC columns are the narrow bore, microbore, microcapillary, and nano-LC models. These columns have smaller internal diameters, allow for a more efficient separation, and handle liquid flows under 1 ml/min (the conventional flow-rate). In order to improve separation efficiency and peak resolution, ultra performance liquid chromatography (UHPLC) can be used instead of HPLC. This LC variant uses columns packed with smaller silica particles (about 1.7 μm diameter) and requires higher operating pressures in the range of 310000 to 775000 torr (6000 to 15000 psi, 400 to 1034 bar).
=== Drug transport === South American cartels and Moroccan crime syndicates have maintained good relationships, and created trafficking networks to transport cargoes that involved thousands of containers through Moroccan ports since the 1980s. Due to the large waves of Moroccan immigration to the Netherlands and Belgium, beginning Moroccan traffickers were able to infiltrate the ports of Rotterdam and Antwerp, and criminal networks were eventually able to grow their influences over these port cities. In the 2000s, drug traffickers in these port-cities have changed the use of their hashish and cannabis routes for the use of cocaine trafficking to gain larger profits. A large part of these traffickers came from the north of Morocco, which explains their ease in expressing themselves in the Spanish language. With the arrival of new communication technologies, it was easier for these organisations to create and maintain new contacts, and networks were eventually established over three continents. The Moroccan mafia in the Netherlands and Belgium dominate the European market for cocaine, cannabis and synthetic drugs, alongside the Irish Mob, and the Italian (’Ndrangheta and Camorra), Serbian, and Albanian mafia. Moroccan gangs in Amsterdam, Utrecht, and Rotterdam have a firm foothold in importing cocaine from South America, particularly from Peru and Colombia, where Colombian cartels trust Dutch- and Belgian-Moroccan drug traffickers in Antwerp to receive and distribute these drugs.
== ABRF Award == The ABRF Award is presented at the annual ABRF meeting for outstanding contributions to Biomolecular Technologies. Past Award Winners (the years refer to the annual conference at which the award was presented):
The synthetic opioid ketazocine and terpenoid natural product salvinorin A are potent and selective KOR agonists. The KOR also mediates the dysphoria and hallucinations seen with opioids such as pentazocine.
All English stocks held at St Mary's Hospital, London were transferred to more secure facilities at Porton Down and then to the US at the Centers for Disease Control and Prevention (CDC) in Atlanta, Georgia in 1982, and all South African stocks were destroyed in 1983. By 1984, the only known stocks were kept at the CDC in the U.S. and the State Research Center of Virology and Biotechnology (VECTOR) in Koltsovo, Russia. These states report that their repositories are for possible anti-bioweaponry research and insurance if some obscure reservoir of natural smallpox is discovered in the future. Long-term eradication efforts were constantly being delayed because of the distinct political and cultural views different countries had. In the following decades, smallpox became more difficult to ignore, requiring more attention than ever before. In the 1970s, the chief of the WHO SEP (Smallpox Eradication Program), W.A. Henderson, wanted to lead the action and form campaigns that would help eradicate smallpox. His team's efforts worked out to help eradicate smallpox as more health programs formed and countries finally arrived to a mutual agreement on how to handle smallpox in effective ways.
Sources: en.wikipedia.org
Scott Sinclair served as Bioshock's art director. Once the Rapture setting was chosen, the art team began developing concepts of what the city would look like, inside and out. Art Deco worked well as a style for the environments because its large, simple shapes were easy to replicate with few polygons. The artists drew inspiration from a Gotham-style metropolis, with Hugh Ferriss's architectural illustrations and the Art Deco architecture of New York City providing inspiration for the look and massing of Rapture's skyline. Irrational also wanted to stay away from "tropical" art deco as seen in places like Miami Beach as it did not create the feeling they wanted. Hogarth De La Plante recalled that the team did not want to be too rigid in following a look, instead adapting the style according to their needs. The game's lead level designer was Bill Gardner. He cited Capcom's survival horror series Resident Evil as a significant influence on BioShock, stating there are "all these nods and all these little elements that I think you can see where Resident Evil inspired us". The team were particularly influenced by Resident Evil 4, including its approach to the environments, combat, and tools, its game design and tactical elements, its "gameplay fuelled storytelling" and inventory system, and its opening village level in terms of how it "handled the sandbox nature of the combat" and in terms of "the environment". The focus on a console release helped Irrational refine and simplify the gameplay to make it more accessible.
== Further reading == Goel, Arun; Shrivastava, Prabhat (2010). "Post-burn scars and scar contractures". Indian Journal of Plastic Surgery. 43 (3). Georg Thieme Verlag KG: S63-71. doi:10.4103/0970-0358.70724. ISSN 0970-0358. PMC 3038392. PMID 21321660. Schneider, Jeffrey C.; Holavanahalli, Radha; Helm, Phala; Goldstein, Richard; Kowalske, Karen (2006). "Contractures in Burn Injury: Defining the Problem". Journal of Burn Care & Research. 27 (4). Oxford University Press (OUP): 508–514. doi:10.1097/01.bcr.0000225994.75744.9d. ISSN 1559-047X. PMID 16819356. S2CID 14982395.
Several characters from the series also appeared in Minna Atsumare! Falcom Gakuen, a four-part comedy manga which later saw two short anime adaptations in the mid-2010s. Audio drama adaptations of the games have also been produced, with a few set between the games and filling in details glossed over. Transcripts of two Trails of Cold Steel dramas were translated by Xseed Games and published online as promotional material for Trails of Cold Steel II. A 2.5D musical based on Trails of Cold Steel ran in January 2017. The Legend of Heroes: Trails of Destiny, a tabletop game designed by Promethium Books, was released in 2024. A trading card game by TCG Corporation was released in Japan in November 2024.
The concentrations of the different species of DIC (and which species is dominant) depends on the pH of the solution, as shown by a Bjerrum plot. Total inorganic carbon is typically measured by the acidification of the sample which drives the equilibria to CO2. This gas is then sparged from solution and trapped, and the quantity trapped is then measured, usually by infrared spectroscopy.
Sources: en.wikipedia.org
On 3 January 2026, the United States launched a military strike in Venezuela and captured incumbent Venezuelan president Nicolás Maduro and his wife, Cilia Flores. The US operation, codenamed Operation Absolute Resolve, began around 2 a.m. local time, when explosions were observed. The US Armed Forces bombed infrastructure across northern Venezuela to suppress air defenses as an apprehension force attacked Maduro's compound in Caracas. Approximately 80 people, including Venezuelan and Cuban military and civilians, died and seven American soldiers were wounded. Maduro and Flores were transported to New York City by US forces and were indicted on drug trafficking charges to which Maduro and Flores pleaded not guilty. US president Donald Trump and his administration justified the operation as a law-enforcement action with military support, saying that the president has "inherent constitutional authority" to undertake such an act. Venezuelan vice president Delcy Rodríguez denounced Maduro's "kidnapping". Venezuelan officials said at least 23 Venezuelan security officers were killed during the attack. The Cuban government said that 32 members of the Cuban military and intelligence agencies were killed. Officials in the United Nations (UN), the US, and other countries, as well as international law experts said the raid violated the UN Charter and Venezuela's sovereignty. Other reactions around the world included celebrations by the Venezuelan diaspora and protests against the attack.
==== Drug delivery ==== Emerging methods of drug delivery involving nanotechnological methods can be useful by improving bodily response, specific targeting, and non-toxic metabolism. Many nanotechnological methods and materials can be functionalized for drug delivery. Ideal materials employ a controlled-activation nanomaterial to carry a drug cargo into the body. Mesoporous silica nanoparticles (MSN) have increased in research popularity due to their large surface area and flexibility for various individual modifications while maintaining high-resolution performance under imaging techniques. Activation methods greatly vary across nanoscale drug delivery molecules, but the most commonly used activation method uses specific wavelengths of light to release the cargo. Nanovalve-controlled cargo release uses low-intensity light and plasmonic heating to release the cargo in a variation of MSN containing gold molecules. The two-photon activated photo-transducer (2-NPT) uses near infrared wavelengths of light to induce the breaking of a disulfide bond to release the cargo. Recently, nanodiamonds have demonstrated potential in drug delivery due to non-toxicity, spontaneous absorption through the skin, and the ability to enter the blood–brain barrier. The unique structure of carbon nanotubes also gives rise to many innovative inventions of new medical methods. As more medicine is made at the nano level to revolutionize the ways for human to detect and treat diseases, carbon nanotubes become a stronger candidate in new detection methods and therapeutic strategies.
The United States National Academy of Medicine recommends against consuming large amounts. Vitamin C was discovered in 1912, isolated in 1928, and in 1933, was the first vitamin to be chemically produced. Partly for its discovery, Albert Szent-Györgyi was awarded the 1937 Nobel Prize in Physiology or Medicine.
Alcohol: It has been reported that combined use of alcohol and kava extract can have additive sedative effects. Kava has been shown to create additive cognitive impairments when taken with alcohol, compared to taking placebo and alcohol alone. Anxiolytics (CNS depressants such as benzodiazepines and barbiturates): Kava may have potential additive CNS depressant effects (such as sedation and anxiolytic effects) with benzodiazepines and barbiturates. Kava taken in combination with alprazolam can cause a semicomatose state in humans. Dopamine agonist such as levodopa: One of levodopa's chronic side effects in Parkinson's patients is the "on-off phenomenon" of motor fluctuations - periods of oscillations between "on", where the patient experiences symptomatic relief, and "off", where the therapeutic effect wears off early. When levodopa and kava are taken together, it has been shown that there is an increased frequency of this "on-off phenomenon".
MPs approve the amended Universal Credit Bill. Former Conservative Party Chair and MP Sir Jake Berry announces he is defecting to Reform UK. Reform UK councillor Mandy Clare is suspended from her job in the office of Sarah Pochin pending a court date. DUP councillor Linda Clarke is suspended from Antrim and Newtownabbey Borough Council. 10 July – Kemi Badenoch says Conservative politicians who want to join Reform UK are "welcome to do so". Liberal Democrat Spokesperson for Women and Equalities Christine Jardine is removed from the frontbench after she rebelled on a welfare vote. Bert Bingham, Reform UK's cabinet member for transport and environment at Nottinghamshire County Council, faces criticism after saying that man-made climate change is a "hoax" during a public meeting. 11 July – Unite the Union votes to suspend Angela Rayner's membership following a long running dispute over her role in the Birmingham bin strike. The Parliamentary Commissioner for Standards launches an investigation into Rupert Lowe over allegations he failed to register money raised in donations to fund his independent "Rape Gang Inquiry". He is subsequently cleared later the same day following a brief investigation. 18-year-old George Finch is installed as permanent leader of the Reform group at Warwickshire County Council. 14 July – It is confirmed that Keir Starmer and John Swinney will meet US President Donald Trump when he travels to Scotland later in July for the opening of his golf course at Menie, Aberdeenshire.
Sources: en.wikipedia.org
Mass spectrometry provides the most direct confirmation of molecular mass. Reversed-phase chromatography adds a retention-time signature that supports identity when compared against a reference standard. No single method is sufficient on its own.
Cool, dry conditions with desiccant are standard for the solid form. Long-term storage is usually at freezer temperatures, with short-term handling at refrigerator temperature. Vials are allowed to equilibrate before opening to prevent condensation.
Lipid conjugation increases hydrophobicity, which shifts chromatographic retention and can broaden peaks. It also creates additional related species when acylation is incomplete or the chain is oxidised. Methods are therefore developed to separate acylated and non-acylated forms explicitly.
It is described as a single molecule that acts at three receptors: the glucose-dependent insulinotropic polypeptide receptor, the glucagon-like peptide-1 receptor, and the glucagon receptor. This triple activity distinguishes it from agents that target one or two of these pathways.